These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30342555)

  • 41. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review.
    Gizzo S; Patrelli TS; Gangi SD; Carrozzini M; Saccardi C; Zambon A; Bertocco A; Fagherazzi S; D'Antona D; Nardelli GB
    Reprod Sci; 2013 Sep; 20(9):1011-9. PubMed ID: 23296037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.
    Lawrie TA; Rogozińska E; Sobiesuo P; Vogel JP; Ternent L; Oladapo OT
    Int J Gynaecol Obstet; 2019 Jul; 146(1):56-64. PubMed ID: 31049950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials.
    Kalafat E; Gokce A; O'Brien P; Benlioglu C; Koc A; Karaaslan O; Khalil A
    J Matern Fetal Neonatal Med; 2021 Jul; 34(14):2303-2316. PubMed ID: 31537134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active versus expectant management for women in the third stage of labour.
    Begley CM; Gyte GM; Devane D; McGuire W; Weeks A; Biesty LM
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD007412. PubMed ID: 30754073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial.
    Calişkan E; Meydanli MM; Dilbaz B; Aykan B; Sönmezer M; Haberal A
    Am J Obstet Gynecol; 2002 Oct; 187(4):1038-45. PubMed ID: 12389002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial.
    Quibel T; Ghout I; Goffinet F; Salomon LJ; Fort J; Javoise S; Bussieres L; Aegerter P; Rozenberg P;
    Obstet Gynecol; 2016 Oct; 128(4):805-11. PubMed ID: 27607864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan.
    Zuberi NF; Durocher J; Sikander R; Baber N; Blum J; Walraven G
    BMC Pregnancy Childbirth; 2008 Aug; 8():40. PubMed ID: 18718007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section].
    Jagielska I; Kazdepka-Ziemińska A; Kaczorowska A; Madej A; Kolossa T; Grabiec M
    Ginekol Pol; 2015 Sep; 86(9):689-93. PubMed ID: 26665571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Misoprostol versus ergometrine-oxytocin for preventing postpartum haemorrhage: a systematic review and meta-analysis of randomized controlled trials.
    Tan J; Cao Q; He GL; Cai YH; Yu JJ; Sun X; Li YP
    J Evid Based Med; 2016 Nov; 9(4):194-204. PubMed ID: 27187008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour.
    Afolabi EO; Kuti O; Orji EO; Ogunniyi SO
    Singapore Med J; 2010 Mar; 51(3):207-11. PubMed ID: 20428741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
    Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
    BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management.
    Karkanis SG; Caloia D; Salenieks ME; Kingdom J; Walker M; Meffe F; Windrim R
    J Obstet Gynaecol Can; 2002 Feb; 24(2):149-54. PubMed ID: 12196880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
    Lam H; Tang OS; Lee CP; Ho PC
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbetocin vs oxytocin for prevention of postpartum hemorrhage after vaginal delivery: A meta-analysis.
    Jin XH; Li D; Li X
    Medicine (Baltimore); 2019 Nov; 98(47):e17911. PubMed ID: 31764790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings.
    Lang DL; Zhao FL; Robertson J
    BMC Pregnancy Childbirth; 2015 Nov; 15():305. PubMed ID: 26596797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Misoprostol and active management of the third stage of labor.
    Prata N; Hamza S; Gypson R; Nada K; Vahidnia F; Potts M
    Int J Gynaecol Obstet; 2006 Aug; 94(2):149-55. PubMed ID: 16828767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between Carbetocin and Oxytocin in Active Management of 3rd Stage of Labour in Preventing Post Partum Hemorrhage.
    Akhter P; Pal SN; Begum S
    Mymensingh Med J; 2018 Oct; 27(4):793-797. PubMed ID: 30487496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Misoprostol for prevention of postpartum hemorrhage.
    Bugalho A; Daniel A; Faúndes A; Cunha M
    Int J Gynaecol Obstet; 2001 Apr; 73(1):1-6. PubMed ID: 11336714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study.
    Wohling J; Edge N; Pena-Leal D; Wang R; Mol BW; Dekker G
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):501-507. PubMed ID: 30411314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.